CLINICAL_TRIALS ClinicalTrials.gov record update

An Open, Phase I/II Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' 11PCV Vaccine Given as a 2-Dose Vaccination in Adults Aged 18-40 Years Old.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00327522
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:34:54.268046+00:00
Published At: 2008-10-13T00:00:00+00:00
Record Updated At: 2008-10-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Prophylactic Pneumococcal Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2008-10-13"
protocolSection.identificationModule.nctId: "NCT00327522"
protocolSection.identificationModule.officialTitle: "An Open, Phase I/II Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals\u0027 11PCV Vaccine Given as a 2-Dose Vaccination in Adults Aged 18-40 Years Old."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.